Literature DB >> 28266965

Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer.

Paul J Speicher1, Brian R Englum, Asvin M Ganapathi, Xiaofei Wang, Matthew G Hartwig, Thomas A D'Amico, Mark F Berry.   

Abstract

BACKGROUND: An association between volume and outcomes has been observed for esophagectomy, though little is known about why or how patients choose low- or high-volume centers. The purpose of this study was to evaluate how travel burden and hospital volume influence treatment and outcomes of patients with locally advanced esophageal cancer.
METHODS: Predictors of receiving esophagectomy for patients with T1-3N1M0 mid or distal esophageal cancer in the National Cancer Data Base from 2006 to 2011 were identified using multivariable logistic regression. Survival was compared using propensity score-matched groups: patients in the bottom quartile of travel distance who underwent treatment at low-volume facilities (Local) and patients in the top quartile of travel distance who underwent treatment at high-volume facilities (Travel).
RESULTS: Of 4979 patients who met inclusion criteria, we identified 867 Local patients who traveled 2.7 [interquartile range (IQR): 1.6-4 miles] miles to centers that treated 2.6 (IQR: 1.9-3.3) esophageal cancers per year, and 317 Travel patients who traveled 107.1 (IQR: 65-247) miles to centers treating 31.9 (IQR: 30.9-38.5) cases. Travel patients were more likely to undergo esophagectomy (67.8% vs 42.9%, P < 0.001) and had significantly better 5-year survival (39.8% vs 20.6%, P < 0.001) than Local patients.
CONCLUSIONS: Patients who travel longer distances to high-volume centers have significantly different treatment and better outcomes than patients who stay close to home at low-volume centers. Strategies that support patient travel for treatment at high-volume centers may improve esophageal cancer outcomes.

Entities:  

Mesh:

Year:  2017        PMID: 28266965      PMCID: PMC5143210          DOI: 10.1097/SLA.0000000000001702

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  37 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients.

Authors:  Jeffrey Rentz; David Bull; David Harpole; Stephen Bailey; Leigh Neumayer; Theodore Pappas; Barbara Krasnicka; William Henderson; Jennifer Daley; Shukri Khuri
Journal:  J Thorac Cardiovasc Surg       Date:  2003-05       Impact factor: 5.209

3.  Outcomes after esophagectomy: a ten-year prospective cohort.

Authors:  Stephen H Bailey; David A Bull; David H Harpole; Jeffrey J Rentz; Leigh A Neumayer; Theodore N Pappas; Jennifer Daley; William G Henderson; Barbara Krasnicka; Shukri F Khuri
Journal:  Ann Thorac Surg       Date:  2003-01       Impact factor: 4.330

4.  National trends in outcomes for esophageal resection.

Authors:  Justin B Dimick; Reid M Wainess; Gilbert R Upchurch; Mark D Iannettoni; Mark B Orringer
Journal:  Ann Thorac Surg       Date:  2005-01       Impact factor: 4.330

5.  Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals.

Authors:  Thomas W Rice; Valerie W Rusch; Hemant Ishwaran; Eugene H Blackstone
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860

6.  Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort.

Authors:  Grace L Smith; Benjamin D Smith; Thomas A Buchholz; Zhongxing Liao; Melenda Jeter; Stephen G Swisher; Wayne L Hofstetter; Jaffer A Ajani; Mary F McAleer; Ritsuko Komaki; James D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-14       Impact factor: 7.038

7.  Esophagectomy compared with chemoradiation for early stage esophageal cancer in the elderly.

Authors:  Julian A Abrams; Donna L Buono; Joshua Strauss; Russell B McBride; Dawn L Hershman; Alfred I Neugut
Journal:  Cancer       Date:  2009-11-01       Impact factor: 6.860

Review 8.  Reducing hospital morbidity and mortality following esophagectomy.

Authors:  B Zane Atkins; Ashish S Shah; Kelley A Hutcheson; Jennifer H Mangum; Theodore N Pappas; David H Harpole; Thomas A D'Amico
Journal:  Ann Thorac Surg       Date:  2004-10       Impact factor: 4.330

9.  Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer.

Authors:  David P Kelsen; Katryn A Winter; Leonard L Gunderson; Joanne Mortimer; Norman C Estes; Daniel G Haller; Jaffer A Ajani; Walter Kocha; Bruce D Minsky; Jack A Roth; Christopher G Willett
Journal:  J Clin Oncol       Date:  2007-08-20       Impact factor: 44.544

10.  Access to cancer services for rural colorectal cancer patients.

Authors:  Laura-Mae Baldwin; Yong Cai; Eric H Larson; Sharon A Dobie; George E Wright; David C Goodman; Barbara Matthews; L Gary Hart
Journal:  J Rural Health       Date:  2008       Impact factor: 4.333

View more
  22 in total

1.  Neoadjuvant chemoradiation radiation dose levels for surgically resectable esophageal cancer: predictors of use and outcomes.

Authors:  M Buckstein; R Rhome; M Ru; E Moshier
Journal:  Dis Esophagus       Date:  2018-05-01       Impact factor: 3.429

Review 2.  Gastric Preconditioning in Advance of Esophageal Resection-Systematic Review and Meta-Analysis.

Authors:  Patrick Heger; Susanne Blank; Markus K Diener; Alexis Ulrich; Thomas Schmidt; Markus W Büchler; André L Mihaljevic
Journal:  J Gastrointest Surg       Date:  2017-04-24       Impact factor: 3.452

3.  Potential impact of a volume pledge on spatial access: A population-level analysis of patients undergoing pancreatectomy.

Authors:  Zhi Ven Fong; Andrew P Loehrer; Carlos Fernández-Del Castillo; Yanik J Bababekov; Ginger Jin; Cristina R Ferrone; Andrew L Warshaw; Lara N Traeger; Matthew M Hutter; Keith D Lillemoe; David C Chang
Journal:  Surgery       Date:  2017-05-11       Impact factor: 3.982

4.  Simulated Volume-Based Regionalization of Complex Procedures: Impact on Spatial Access to Care.

Authors:  Zhi Ven Fong; Daniel A Hashimoto; Ginger Jin; Alex B Haynes; Numa Perez; Motaz Qadan; Cristina R Ferrone; Carlos Fernandez-Del Castillo; Andrew L Warshaw; Keith D Lillemoe; Lara N Traeger; David C Chang
Journal:  Ann Surg       Date:  2021-08-01       Impact factor: 12.969

Review 5.  Regionalization of esophagectomy: where are we now?

Authors:  James M Clark; Daniel J Boffa; Robert A Meguid; Lisa M Brown; David T Cooke
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

6.  Optimal Therapy in Locally Advanced Esophageal Cancer: a National Cancer Database Analysis.

Authors:  William M Whited; Jaimin R Trivedi; Emily R Bond; Victor H van Berkel; Matthew P Fox
Journal:  J Gastrointest Surg       Date:  2017-09-22       Impact factor: 3.452

7.  Factors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of Care.

Authors:  Joshua Sterling; Zorimar Rivera-Núñez; Hiren V Patel; Nicholas J Farber; Sinae Kim; Kushan D Radadia; Parth K Modi; Sharad Goyal; Rahul Parikh; Robert E Weiss; Isaac Y Kim; Sammy E Elsamra; Thomas L Jang; Eric A Singer
Journal:  Clin Genitourin Cancer       Date:  2020-03-20       Impact factor: 2.872

8.  The impact of traveling distance and hospital volume on post-surgical outcomes for patients with glioblastoma.

Authors:  Christian Lopez Ramos; Michael G Brandel; Jeffrey A Steinberg; Arvin R Wali; Robert C Rennert; David R Santiago-Dieppa; Reith R Sarkar; J Scott Pannell; James D Murphy; Alexander A Khalessi
Journal:  J Neurooncol       Date:  2018-11-20       Impact factor: 4.130

9.  Disparities in esophageal cancer: less treatment, less surgical resection, and poorer survival in disadvantaged patients.

Authors:  Francisco Schlottmann; Charles Gaber; Paula D Strassle; Fernando A M Herbella; Daniela Molena; Marco G Patti
Journal:  Dis Esophagus       Date:  2020-03-05       Impact factor: 3.429

10.  Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers?

Authors:  Alexander L Lazarides; David L Kerr; Daniel P Nussbaum; R Timothy Kreulen; Jason A Somarelli; Dan G Blazer; Brian E Brigman; William C Eward
Journal:  Clin Orthop Relat Res       Date:  2019-04       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.